Implications of cardiac markers in risk-stratification and management for COVID-19 patients | Critical Care | Full Text
Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized With COVID‐19: Derivation and Validation of the HA2T2 COVID‐19 Mortality Risk Score | Journal of the American Heart Association
Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics | Laboratory Investigation
Current and innovative methods for the diagnosis of COVID‑19 infection (Review)
The High-Sensitivity C-Reactive Protein Level One Month After Bare-Metal Coronary Stenting May Predict Late Adverse Events | Revista Española de Cardiología
Frontiers | Significance of Cardiac Troponins as an Identification Tool in COVID-19 Patients Using Biosensors: An Update
High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis | Journal of the American College of Cardiology
High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease | Revista Portuguesa de Cardiologia (English edition)
Implications of cardiac markers in risk-stratification and management for COVID-19 patients | Critical Care | Full Text
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women | NEJM
Cardiovascular manifestations and treatment considerations in COVID-19 | Heart
Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases | Metabolic Syndrome and Related Disorders
Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA | Nature Communications
SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association | Circulation
Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction | Scientific Reports
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases - Heart
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 | Heart
Frontiers | Predictive Factor for COVID-19 Worsening: Insights for High- Sensitivity Troponin and D-Dimer and Correlation With Right Ventricular Afterload
High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease | Revista Portuguesa de Cardiologia (English edition)
Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients - Journal of Molecular and Cellular Cardiology
Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases - ScienceDirect
Implications of cardiac markers in risk-stratification and management for COVID-19 patients | Critical Care | Full Text
